glp 1 adverse events Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Key Facts GPs Should Know

Market Opportunity: Advancements in dual and triple agonist therapies acts as an opportunity for the GLP-1 Receptor Agonist market

McLean BA, Wong CK, Kaur KD, Seeley RJ, Drucker DJ (2021) Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide

2024;47(Suppl 1):S1S308

Use a five-bites-then-pause approach

A patient who has been stable on a maintenance dose for months without gastrointestinal symptoms may have lower practical risk than a patient who recently started therapy, recently increased the dose, has nausea or vomiting, or has known diabetic gastroparesis

These drugs treat chronic conditions requiring ongoing management, though individual circumstances and consultation with your healthcare provider should guide discontinuation decisions